Mutations in the glucose-6-phosphatase (G6Pase) gene are responsible for gl
ycogen storage disease type Ia (GSDIa). This disease is characterized by gr
owth retardation, hepatomegaly, hypoglycemia, hyperlipidemia, and lactic ac
idosis. In this study, we report mutations in the G6Pase gene in 8 of 25 Br
azilian patients with clinical symptoms of GSDIa. Five previously described
mutations (R83C, Q347X, V338F, D38V, and G68R) were detected. The two most
common mutations identified were R83C and Q347X, accounting for 8 of 14 (5
7.14%) mutant alleles. A 1176 single-nucleotide polymorphism and two intron
ic mutations (IVS3-58T>A and IVS4+10G>A) were also analyzed. We used the mi
nigene strategy in order to verify the effect of these intronic mutations o
n the splicing mechanism. This study emphasizes that molecular genetic anal
ysis is a reliable and convenient alternative to the assay of enzyme activi
ty in a fresh liver biopsy specimen for dianosing GSDIa.